Skip to content

Tegarderm® Placement for Bag Mask Ventilation in the Bearded Patient

Efficacy of Tegarderm® Placement for Bag Mask Ventilation in the Bearded Patient

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04274686
Enrollment
25
Registered
2020-02-18
Start date
2020-02-12
Completion date
2021-05-03
Last updated
2022-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Ventilation

Keywords

Tegaderm bandage, Bag mask ventilation

Brief summary

Difficult Bag Mask Ventilation is well described in the anesthesiology literature, and bearded patients are likely to experience this phenomenon. This study involves application of a large and perforated Tegaderm® across the lower face of the bearded patient to quantify its effectiveness at improving mask ventilation in this anesthetized population.

Detailed description

This study is a prospective crossover trial in bearded patients who will undergo elective or urgent surgery at the main operating rooms of the University of New Mexico Hospital. It is planned to test the efficacy of the novel bag mask ventilation augmentation technique of placing a large perforated Tegaderm® over the mouth of bearded male patients in order to improve seal after induction of general anesthesia. The perforation is a diamond-shaped hole to be aligned with the patient's mouth. Patients will either start with Tegaderm application or without Tegaderm, and will then cross over to the other condition in order to be their own controls. The primary endpoint is to measure inspiratory and expiratory tidal volumes. If shown efficacious this intervention would be an easy and cost-effective intervention to improve bag mask ventilation for bearded patients in the operating room and non-operating room environments alike.

Interventions

DEVICETegaderm placement

Placement of perforated Tegaderm bandage over lower face, with diamond-shaped hole aligned with the patient's mouth, for use during bag-mask ventilation

OTHERNo Tegaderm

Bag-mask ventilation performed in ordinary fashion, without use of Tegaderm bandage

Sponsors

University of New Mexico
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patients with perioral facial hair \>5mm in length * Undergoing elective non-cardiac surgery with planned bag-mask ventilation during anesthesia induction

Exclusion criteria

* Known allergy to Tegaderm product and/or its adhesive * Emergency surgery * Active or unstable cardiac disease * ASA (American Society of Anesthesiologists) physical status ≥4 * External or internal active airway obstruction from tumor, abscess, or laryngeal edema * Organic or non-organic oropharyngeal anatomical defects including history of radiation treatment to the neck * Moderate to severe acute and chronic restrictive or obstructive lung diseases, e.g. chronic obstructive pulmonary disease, asthma, etc. * Requirement for rapid sequence intubation, or known aspiration risk * Cervical spine injury * Previously documented difficult mask ventilation or intubation * BMI ≥50 * Vulnerable populations: children, prisoners, pregnant patients, cognitively impaired adults

Design outcomes

Primary

MeasureTime frameDescription
Percent Air Leakage During Bag-mask Ventilation<5 minutesLeakage defined as difference in inspired and expired tidal volumes during bag-mask ventilation, as a percentage of inspired tidal volume.

Secondary

MeasureTime frameDescription
Resistance<5 minutesAirflow resistance during bag-mask ventilation
Peak Inspiratory Pressure<5 minutesMaximum air pressure observed during bag-mask ventilation

Countries

United States

Participant flow

Participants by arm

ArmCount
All Study Participants
All participants in the study
25
Total25

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyPhysician Decision10

Baseline characteristics

CharacteristicAll Study Participants
Age, Continuous59 years
STANDARD_DEVIATION 15
Beard Length
>1 cm
8 Participants
Beard Length
1 cm
6 Participants
Beard Length
5-9 mm
3 Participants
Beard Length
5 mm
8 Participants
Race and Ethnicity Not Collected— Participants
Region of Enrollment
United States
25 participants
Sex: Female, Male
Female
1 Participants
Sex: Female, Male
Male
24 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 250 / 25
other
Total, other adverse events
0 / 250 / 25
serious
Total, serious adverse events
0 / 250 / 25

Outcome results

Primary

Percent Air Leakage During Bag-mask Ventilation

Leakage defined as difference in inspired and expired tidal volumes during bag-mask ventilation, as a percentage of inspired tidal volume.

Time frame: <5 minutes

ArmMeasureValue (MEAN)Dispersion
Bag-mask Ventilation With Tegaderm PlacementPercent Air Leakage During Bag-mask Ventilation47.6 percentage of inspired tidal volumeStandard Deviation 26.2
Bag-mask Ventilation Without Tegaderm PlacementPercent Air Leakage During Bag-mask Ventilation45.7 percentage of inspired tidal volumeStandard Deviation 20.4
Comparison: Null hypothesis: No difference in percent air leakagep-value: 0.66795% CI: [-7, 10.7]Paired t-test
Secondary

Peak Inspiratory Pressure

Maximum air pressure observed during bag-mask ventilation

Time frame: <5 minutes

ArmMeasureValue (MEAN)Dispersion
Bag-mask Ventilation With Tegaderm PlacementPeak Inspiratory Pressure19.3 cm H2OStandard Deviation 1.6
Bag-mask Ventilation Without Tegaderm PlacementPeak Inspiratory Pressure19.4 cm H2OStandard Deviation 1.3
p-value: 0.45595% CI: [-0.5, 0.2]Paired t-test
Secondary

Resistance

Airflow resistance during bag-mask ventilation

Time frame: <5 minutes

ArmMeasureValue (MEAN)Dispersion
Bag-mask Ventilation With Tegaderm PlacementResistance8.83 cm H2O/L/sStandard Deviation 5.57
Bag-mask Ventilation Without Tegaderm PlacementResistance7.73 cm H2O/L/sStandard Deviation 3.69
p-value: 0.21895% CI: [-0.7, 2.9]Paired t-test

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026